Case of bullous pemphigoid following coronavirus disease 2019 vaccination
Corresponding Author
Kenta Nakamura
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Correspondence
Kenta Nakamura, Department of Dermatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan.
Email: [email protected]
Search for more papers by this authorMegumi Kosano
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorYuzuki Sakai
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorNana Saito
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorYuko Takazawa
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorToshikazu Omodaka
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorYukiko Kiniwa
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorRyuhei Okuyama
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorCorresponding Author
Kenta Nakamura
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Correspondence
Kenta Nakamura, Department of Dermatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan.
Email: [email protected]
Search for more papers by this authorMegumi Kosano
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorYuzuki Sakai
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorNana Saito
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorYuko Takazawa
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorToshikazu Omodaka
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorYukiko Kiniwa
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorRyuhei Okuyama
Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan
Search for more papers by this authorCONFLICT OF INTEREST
None declared.
REFERENCES
- 1Pérez-López I, Moyano-Bueno D, Ruiz-Villaverde R. Bullous pemphigoid and COVID-19 vaccine. Med Clin (Barc). 2021. [Epub ahead of print]. https://doi.org/10.1016/j.medcli.2021.05.005
- 2Tomayko MM, Damsky W, Fathy R, McMahon DE, Turner N, Valentin MN, et al. Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination. J Allergy Clin Immunol. 2021; 148: 750–1.
- 3Damiani G, Pacifico A, Pelloni F, Iorizzo M. The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated? J Eur Acad Dermatol Venereol. 2021. 35: e645–e647. https://doi.org/10.1111/jdv.17472
- 4García-Doval I, Mayo E, Fariña JN, Cruces MJ. Bullous pemphigoid triggered by influenza vaccination? Ecological study in Galicia, Spain. Br J Dermatol. 2006; 155: 820–3.
- 5Navarro-Navarro I, Jiménez-Gallo D, Valenzuela-Ubiña S, Domínguez-Gomez M, Linares-Barrios M. Infantile bullous pemphigoid following serogroup B meningococcal vaccination. Br J Dermatol. 2021; 184: e53.
Citing Literature
